Prevalence of Musculoskeletal Disorders of Upper Limb in Type 1 Diabetes Patients
NCT ID: NCT05164562
Last Updated: 2022-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2022-01-07
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes
NCT06351176
Bone Health and Microbiome in Persons With Type 1 Diabetes
NCT04784975
Prevalence of Vertebral Fractures in Patients With Type 1 Diabetes
NCT04064437
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
NCT05701254
Bone Health in Type 1 Diabetes
NCT00651196
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
type 1 diabetes
"type 1 diabetes" group: patients with type 1 diabetes
Data collection
Description: musculoskeletal disorders of upper limb evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Description: musculoskeletal disorders of upper limb evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged of 18 and more
* with type 1 diabetes
* agreeing to participate in the study
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de Reims
Reims, Grand Est, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-013-TMS-DT1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.